The approval is said to cover a range of clinical indications and supports use in both acute and chronic patients.
MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NUWE) Nuwellis, Inc., a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to ...
MINNEAPOLIS, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the activation of ...